Back to News
Market Impact: 0.05
Aprea Therapeutics to Present at October Conferences
Source: GlobeNewswire
Healthcare & Biotech
The company said it will participate in the 2026 Maxim Growth Summit on October 14 and the Regional Biotechnology Conference on October 15. The notice provides no additional business or financial updates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- BTIG reiterates Vaxcyte stock rating on strong VAX-31 trial data
- Why is NeoGenomics stock sliding today?
- Up 57% since June: this AI-picked pharma stock keeps climbing
- These stocks could benefit from a midterm election shake-up, JPMorgan says
- Vaxcyte shares surge on late-stage vaccine trial success